More specifically, B2m expression is increased in MOG35–55-induced EAE [36] (experimental validation provided in this study) and in cuprizone-induced EAE brain tissue, as well as multiple sclerosis (MS) lesions [65]. This evidence concerns the gene B2M and myeloid sarcoma.